Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2018-10-24 AGM Information
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting/Proxy Form 39 pages 951.2KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and includes detailed information about the AGM such as date, time, location, proxy instructions, and a table of contents listing resolutions to be voted on at the meeting. It includes resolutions related to remuneration reports, re-election of directors, approval to issue options and performance rights, and approval of placement capacity. The document is a notice to shareholders about the upcoming AGM and the matters to be considered, not the actual meeting materials or minutes. It does not contain financial statements or detailed financial performance data but rather the agenda and explanatory memorandum for the AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2018-10-24 English
Change of Director's Interest Notice 2 pages 300.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of interest, and transaction details. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3451 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. There is no indication of financial results, management discussion, or other report types. Therefore, the correct classification is Director's Dealing (DIRS).
2018-10-15 English
Appendix 4G and Corporate Governance Statement 16 pages 816.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures required to be lodged with the ASX alongside the annual report. The content is a detailed key to disclosures against the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2018. It includes a corporate governance statement and explanations of compliance with governance principles, board structure, and policies. There is no financial data or financial statements present, nor is this a report of voting results or management changes. The document is a regulatory filing required by the ASX to disclose corporate governance compliance, not the annual report itself or a presentation. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and detailed governance content support this classification with high confidence.
2018-09-27 English
Annual Report to shareholders 58 pages 2.3MB
Annual Report Classification · 100% confidence The document is titled 'Bioxyne Limited 2018 Financial Report' and contains detailed sections typical of an annual report, including Chairman's Letter, Operations Review, Corporate Governance Statement, Directors' Report, Auditor's Independence Declaration, consolidated financial statements, notes to the financial statements, Directors' Declaration, and Independent Auditor's Report. The content covers the full fiscal year ended 30 June 2018, with comprehensive financial data and management commentary. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. These characteristics align with the definition of an Annual Report (10-K equivalent). FY 2018
2018-09-27 English
Bioxyne Expands to Indonesia with Acquisition 2 pages 684.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX/Media Announcement dated 25 September 2018 about Bioxyne Limited's acquisition of a 95% interest in an Indonesian direct sales company, P.T. Gamat Utama. The content focuses on the acquisition details, strategic expansion, and financial terms related to the transaction. There are no financial statements, quarterly or annual results, nor is this a report or presentation. It is a corporate announcement about a capital transaction (acquisition) expanding the company's operations. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes through acquisition. The document length is under 5,000 characters and is not merely announcing a report publication but providing substantive information about the acquisition itself. Therefore, the correct classification is CAP with high confidence.
2018-09-24 English
Preliminary Final Report 35 pages 961.4KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E' and relates to the financial results for the year ended 30 June 2018, with comparative figures for the previous year. It includes detailed financial statements such as the Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. The document also contains notes to the financial statements and commentary on results, revenue, expenditure, balance sheet, cash flow, and outlook. The length is substantial (15,000 characters), and it contains actual financial data and analysis for a full fiscal year. The presence of an Appendix 4E filing, which is an Australian Securities Exchange (ASX) form for preliminary final reports, aligns with an annual report or full year financial report. Given the comprehensive financial data and the reporting period of a full year, this document fits the definition of an Annual Report (10-K equivalent). FY 2018
2018-08-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.